Ana is a molecular biologist enthusiastic about innovation and communication. In her role as a science writer she wishes to bring the advances in medical science and technology closer to the public, particularly to those most in need of them. Ana holds a PhD in Biomedical Sciences from the University of Lisbon, Portugal, where she focused her research on molecular biology, epigenetics and infectious diseases.
Caregivers of younger children with fragile X syndrome (FXS), and those with lower family incomes, report more difficulties in accessing specialized healthcare in the U.S., a recent study found. ... Read more
Early Check, a free newborn screening program for fragile X syndrome (FXS) that recently began testing in North Carolina, will address the feasibility of implementing an expanded newborn screening for fragile X ... Read more
Lovastatin, a medication widely prescribed for lowering cholesterol, was recently discovered to correct brain deficits linked with fragile X syndrome in mouse models of the disease. The finding prompted clinical ... Read more
Chemical modification of a DNA-binding protein may provide a new therapeutic target to treat fragile X syndrome (FXS), a mouse study suggests. The study, “Reducing histone acetylation rescues cognitive deficits in ... Read more
A University of Virginia scientist has won the Hartwell Individual Biomedical Research Award for her work on neurodevelopmental disorders that occur during childhood. The research of Sanchita Bhatnagar, PhD, will be funded ... Read more
The University of California at Davis’s MIND Institute is recruiting children and young adults with fragile X syndrome for clinical trials dealing with learning spoken language. A key focus of the ... Read more
Pin It on Pinterest